Literature DB >> 4343211

Aggravation of broad- disease (type 3 hyperlipoproteinemia) by hypothyroidism.

W R Hazzard, E L Bierman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4343211

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


× No keyword cloud information.
  10 in total

Review 1.  Plasma lipoproteins, lipid transport, and atherosclerosis: recent developments.

Authors:  N E Miller
Journal:  J Clin Pathol       Date:  1979-07       Impact factor: 3.411

2.  Pre-beta-very low density lipoproteins as precursors of beta-very low density lipoproteins. A model for the pathogenesis of familial dysbetalipoproteinemia (type III hyperlipoproteinemia).

Authors:  D A Chappell
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

3.  High receptor binding affinity of lipoproteins in atypical dysbetalipoproteinemia (type III hyperlipoproteinemia).

Authors:  D A Chappell
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

4.  Thyroid hormone action on intermediary metabolism. Part II: Lipid metabolism in hypo- and hyperthyroidism.

Authors:  M J Müller; H J Seitz
Journal:  Klin Wochenschr       Date:  1984-01-16

5.  The influence of simvastatin alone or in combination with gemfibrozil on plasma lipids and lipoproteins in patients with type III hyperlipoproteinemia.

Authors:  G Feussner; M Eichinger; R Ziegler
Journal:  Clin Investig       Date:  1992-11

6.  Hyperlipidemia in coronary heart disease. 3. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction.

Authors:  W R Hazzard; J L Goldstein; M G Schrott; A G Motulsky; E L Bierman
Journal:  J Clin Invest       Date:  1973-07       Impact factor: 14.808

7.  Hypothyroidism as a risk factor for development of cardiovascular disease in patients with rheumatoid arthritis.

Authors:  Sara S McCoy; Cynthia S Crowson; Sherine E Gabriel; Eric L Matteson
Journal:  J Rheumatol       Date:  2012-02-15       Impact factor: 4.666

8.  Sheehan's syndrome presenting with type III hyperlipoproteinaemia.

Authors:  D Carr; H M Thornes; A C Rutter; R D Finney; P R Turner
Journal:  Postgrad Med J       Date:  1987-12       Impact factor: 2.401

9.  Type III hyperlipoproteinemia in a patient with idiopathic hemochromatosis.

Authors:  G Feussner; R Ziegler
Journal:  Hum Genet       Date:  1991-01       Impact factor: 4.132

10.  Relationship of dietary iodide and drinking water disinfectants to thyroid function in experimental animals.

Authors:  N W Revis; P McCauley; G Holdsworth
Journal:  Environ Health Perspect       Date:  1986-11       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.